Keep track of Closely (two)pentobarbital will decrease the extent or effect of suvorexant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Robust CYP3A4 inducers may reduce suvorexant efficacy; if elevated suvorexant dose expected, don't exceed twenty mg/working day